Satsuma Pharmaceuticals Inc (STSA)
US80405P1075 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.53M | 16.43M | 15.84M | 36.30M | 22.80M | |||
| Marketable Securities | 21.84M | 36.05M | 77.31M | 31.90M | 84.90M | |||
| Other Current Assets | 2.00M | 2.33M | 6.70M | 5.60M | 7.00M | |||
| Total Current Assets | 43.38M | 54.81M | 99.85M | 73.80M | 114.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 82.00K | 108.00K | 6.79M | 6.50M | 800.00K | |||
| Investments And Advances | N/A | 0.00 | 2.62M | N/A | 10.20M | |||
| Other Non-Current Assets | 22.00K | 22.00K | 572.00K | 800.00K | 500.00K | |||
| Total Non-Current Assets | 104.00K | 130.00K | 9.98M | 7.20M | 11.60M | |||
| TOTAL ASSETS | 43.48M | 54.94M | 109.83M | 81.00M | 126.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 1.08M | 2.00M | 2.00M | |||
| Accrued Expenses | 4.96M | 6.20M | 5.94M | 2.70M | 1.70M | |||
| Accounts Payable | 874.00K | 1.91M | 1.47M | 3.40M | 4.30M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 5.83M | 8.12M | 8.49M | 8.00M | 8.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 1.00M | 3.00M | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 1.10M | 2.90M | |||
| TOTAL LIABILITIES | 5.83M | 8.12M | 8.49M | 9.10M | 10.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -222.09M | -211.79M | -141.74M | -90.60M | -43.00M | |||
| Additional Paid In Capital | 259.74M | 258.64M | 243.12M | 162.50M | 158.30M | |||
| Common Shares | 3.00K | 3.00K | 3.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -5.00K | -30.00K | -42.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 33.15M | 33.15M | 31.55M | 17.40M | 17.40M | |||
| Tangible Book Value per Share | 1.14 | 1.41 | 3.21 | 4.13 | 6.63 | |||
| Total Shareholders' Equity | 37.65M | 46.82M | 101.34M | 71.90M | 115.30M | |||
| TOTAL LIABILITIES AND EQUITY | 43.48M | 54.94M | 109.83M | 81.00M | 126.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | 0.03 | |||
| Current Ratio | 7.44 | 6.75 | 11.76 | 9.22 | 14.34 | |||
| Return On Assets (ROA) | -149.11% | -127.51% | -46.59% | -58.72% | -22.31% | |||
| Return On Equity (ROE) | -172.21% | -149.61% | -50.50% | -66.15% | -24.44% | |||
All data in USD